SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biofield may double within 3 months!
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Mike Winn who wrote (59)1/15/1997 2:10:00 PM
From: damniseedemons   of 120
 
Unlike most speculative companies, BZET has an actual, working product. FDA approval is virtually assured to be swift (because it is a scanner, with no possible side-effect. Best of all, their non-invasive scanner has a 95% detection/accuracy rate, and is much more appealing to women than mammograms (which are quite "uncomfortable," I hear).

This could be a huge market....In the long term, BZET should be a very big winner from even these prices. In the shorter-term, I felt that is was suject to profit-taking, so I decided to take profits of my own.

One of these days, I'll probably be buying back all the BZET I sold.

Sal Habash
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News